MDLN
Medline Inc. Class A Common Stock
NASDAQ: MDLN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$43.40
-1.90% today
Updated 2026-04-29
Market cap
$36.70B
P/E ratio
30.35
P/S ratio
1.29x
EPS (TTM)
$1.43
Dividend yield
—
52W range
$35 – $51
Volume
6.6M
Medline Inc. Class A Common Stock (MDLN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 2
Last 2 quarters
Avg EPS surprise
+58.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.2%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-2.2%
2026-02-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $0.38 | +58.3% | $49.99 | $48.89 | -2.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.24 | $0.38 | +58.3% | $7.79B | — |
| 2025-09-30 | $0.00 | $0.31 | — | $7.12B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $1.49 | $31.5B | +10.9% | 28 | high |
| 2027 (E) | $1.68 | $34.0B | +7.7% | 28 | high |
| 2028 (E) | $1.90 | $36.6B | +7.7% | 28 | medium |
| 2029 (E) | $2.12 | $39.1B | +7.1% | 28 | medium |
| 2030 (E) | $2.38 | $41.9B | +7.1% | 28 | medium |
Frequently asked questions
Has Medline Inc. Class A Common Stock beaten earnings estimates?
Medline Inc. Class A Common Stock has beaten Wall Street EPS estimates in 2 of its last 2 quarterly reports, with an average EPS surprise of +58.3% over the last 1 quarters.
How does MDLN stock react to earnings?
MDLN stock has moved an average of -2.2% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.
What is the expected EPS for MDLN in 2026?
Analysts expect Medline Inc. Class A Common Stock to report EPS of $1.49 for fiscal year 2026, on revenue of $31.5B, based on estimates from 28 analysts.